Company Comparison
Pardes Biosciences vs 54gene
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Pardes Biosciences | 54gene |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | Lagos, Nigeria |
| Founded | — | 2019 |
| Status | Active | Active |
| Last Funding Stage | — | Series B |
| Total Funding | — | $45M |
| Valuation | — | — |
What They Build
Pardes Biosciences
Clinical-stage biopharmaceutical company developing oral antiviral therapeutics for infectious diseases.
54gene
African genomics research company advancing precision medicine through genetic research focused on African populations.
Key Investors
Pardes Biosciences
No investors listed.
Sector Overlap
Both Pardes Biosciences and 54gene operate in Biotech.
Browse all Biotech companies →